Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-17T14:52:29.876Z Has data issue: false hasContentIssue false

‘Fair innings’ in the face of ageing and demographic change

Published online by Cambridge University Press:  26 December 2017

Nisha C. Hazra*
Affiliation:
School of Population Health Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, UK
Martin C. Gulliford
Affiliation:
School of Population Health Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, UK National Institutes for Health Research, Biomedical Research Centre at Guy’s and St Thomas’ National Health Service Foundation Trust, London, UK
Caroline Rudisill
Affiliation:
Department of Social Policy, London School of Economics and Political Science, London, UK
*
*Correspondence to: Nisha C. Hazra, School of Population Health Sciences, Faculty of Life Sciences and Medicine, King’s College London, Guy’s Campus, 3rd Floor Addison House, London SE1 1UL, UK. Email: nisha.hazra@kcl.ac.uk

Abstract

There are now 125 million people aged 80 years and over worldwide, projected by the United Nations to grow threefold by 2050. While increases in life expectancy and rapid increases in the older-age population are considered positive developments, the consequential future health care burden represents a leading concern for health services. We revisit Williams’ ‘fair innings’ argument from 1997, in light of technological and demographic changes, and challenge the notion that greater longevity may impose an unfair burden on younger generations. We discuss perspectives on the equity-efficiency trade-off in terms of their implications for the growing over-80 population, as well as society in general. This includes questioning the comparison of treatment cost-effectiveness in younger vs. older populations when using quality-adjusted life years and the transience of life expectancies over generations. While recognising that there will never be a clear consensus regarding societal value judgements, we present empirical evidence on the very elderly that lends support to a stronger anti-ageist stance given current increases in longevity.

Type
Perspective
Copyright
© Cambridge University Press 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aggarwal, A., Fojo, T., Chamberlain, C., Davis, C. and Sullivan, R. (2017), ‘Do patient access schemes for high-cost cancer drugs deliver value to society? – lessons from the NHS Cancer Drugs Fund’, Annals of Oncology, 28(8): 17381750.Google Scholar
Alemayehu, B. and Warner, K. E. (2004), ‘The lifetime distribution of health care costs’, Health Services Research, 39(3): 627642.Google Scholar
Angelis, A. and Kanavos, P. (2016), ‘Value-based assessment of new medical technologies: towards a robust methodological framework for the application of multiple criteria decision analysis in the context of health technology assessment’, Pharmacoeconomics, 34: 435446.Google Scholar
Blagosklonny, M. V. (2010), ‘Why human lifespan is rapidly increasing: solving “longevity riddle” with “revealed-slow-aging” hypothesis’, Aging (Albany NY), 2(4): 177182.Google Scholar
British Heart Foundation (2017), ‘Cardiovascular disease statistics 2017’, https://www.bhf.org.uk/research/heart-statistics/heart-statistics-publications/cardiovascular-disease-statistics-2017 [8 June 2017].Google Scholar
Cookson, R., Drummond, M. and Weatherly, H. (2009), ‘Explicit incorporation of equity considerations into economic evaluation of public health interventions’, Health Economics, Policy and Law, 4(2): 231245.CrossRefGoogle ScholarPubMed
Cookson, R., Mirelman, A. J., Griffin, S., Asaria, M., Dawkins, B., Norheim, O. F., Verguet, S. and Culyer A., J. (2017), ‘Using cost-effectiveness analysis to address health equity concerns.’, Value Health, 20(2): 206212.Google Scholar
Department of Health (2012), ‘The NHS Constitution for England’, https://www.gov.uk/government/publications/the-nhs-constitution-for-england [26 September 2017].Google Scholar
Dong, X., Milholland, B. and Vijg, J. (2016), ‘Evidence for a limit to human lifespan’, Nature, 538(7624): 257259.Google Scholar
Farrant, A. (2009), ‘The fair innings argument and increasing life spans’, Journal of Medical Ethics, 35(1): 5356.Google Scholar
Gawande, A. (2014), Being Mortal: Illness, Medicine, and What Matters in the End, London, UK: Profile Books Ltd.Google Scholar
Hazra, N. C. and Gulliford, M. (2017), ‘Evolution of the “fourth stage” of epidemiologic transition in people aged 80 years and over: population-based cohort study using electronic health records’, Population Health Metrics, 15(1): 18.Google Scholar
Hazra, N. C., Rudisill, C. and Gulliford, M. C. (2017), ‘Determinants of health care costs in the senior elderly: age, comorbidity, impairment, or proximity to death?’, The European Journal of Health Economics, doi: 10.1007/s10198-017-0926-2. [Epub ahead of print].Google Scholar
Hazra, N. C., Dregan, A., Jackson, S. and Gulliford, M. C. (2015), ‘Differences in health at age 100 according to sex: population-based cohort study of centenarians using electronic health records’, Journal of the American Geriatrics Society, 63(7): 13311337.Google Scholar
House of Lords (2005–2006), ‘Science and technology – first report’, http://www.publications.parliament.uk/pa/ld200506/ldselect/ldsctech/20/2002.htm [3 June 2015].Google Scholar
Littlejohns, P., Sharma, T. and Jeong, K. (2012), ‘Social values and health priority setting in England: “values” based decision making’, Journal of Health Organization and Management, 26(3): 363371.CrossRefGoogle ScholarPubMed
Littlejohns, P., Weale, A., Chalkidou, K., Teerwattananon, Y., Faden, R., Littlejohns, P., Sharma, T. and Jeong, K. (2012), ‘Social values and health priority setting in England:“values” based decision making’, Journal of Health Organization and Management, 26(3): 363371.CrossRefGoogle ScholarPubMed
McKeown, T. (1976), The Role of Medicine: Dream, Mirage or Nemesis?, London: Nuffield Trust.Google Scholar
Mody, L., Miller, D. K., McGloin, J. M., Freeman, M., Marcantonio, E. R., Magaziner, J. and Studenski, S. (2008), ‘Recruitment and retention of older adults in aging research’, Journal of the American Geriatrics Society, 56(12): 23402348.Google Scholar
Murray, C. J. L., Ezzati, M., Flaxman, A. D., Lim, S., Lozano, R., Michaud, C., Naghavi, M., Salomon, J. A., Shibuya, K., Vos, T., Wikler, D. and Lopez, A. D. (2012), ‘GBD 2010: design, definitions, and metrics’, The Lancet, 380(9859): 20632066.Google Scholar
Office for National Statistics (2005), ‘The demographic characteristics of the oldest-old in the United Kingdom’, http://www.ons.gov.uk/ons/rel/population-trends-rd/population-trends/no--120--summer-2005/the-demographic-characteristics-of-the-oldest-old-in-the-united-kingdom.pdf [19 March 2015].Google Scholar
Office for National Statistics (2014), ‘Estimates of the very old (including Centenarians) for the United Kingdom, 2002-2012’, http://www.ons.gov.uk/ons/dcp171778_357100.pdf [5 February 2015].Google Scholar
Office for National Statistics (2016), ‘Estimates of the very old (including centenarians), UK, 2002 to 2015’, https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/ageing/bulletins/estimatesoftheveryoldincludingcentenarians/2002to2016 [29 September 2017].Google Scholar
Olshansky, S. J. and Ault, A. B. (1986), ‘The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases’, Milbank Q, 64(3): 355391.CrossRefGoogle ScholarPubMed
Paulden, M., O’Mahony, J. F., Culyer, A. J. and McCabe, C. (2014), ‘Objectivity and equity: clarity required. a response to Hill and Olson’, Pharmacoeconomics, 32(12): 12491250.Google Scholar
Pico della Mirandola, G. (1956), Oration on the Dignity of Man, Washington, DC: Regnery Publishing Inc.Google Scholar
Ravindrarajah, R. and Gulliford, M. (2017), ‘“Progressive dwindling” or “terminal decline” and end of life care’, BMJ, 359: j4772.Google Scholar
Round, J., Jones, L. and Morris, S. (2015), ‘Estimating the cost of caring for people with cancer at the end of life: a modelling study’, Palliative Medicine, 29(10): 899907.Google Scholar
Sato, E. and Fushimi, K. (2009), ‘What has influenced patient health-care expenditures in Japan?: Variables of age, death, length of stay, and medical care’, Health Economics, 18(7): 843853.Google Scholar
United Nations Human Rights (1976), ‘International covenant on economic, social and cultural rights’, O. O. T. H. Commissioner.Google Scholar
US Census Bureau (2012), ‘Centenarians: 2010. 2010 Census Special Reports’, http://www.census.gov/prod/cen2010/reports/c2010sr-03.pdf [16 October 2014].Google Scholar
Wailoo, A., Tsuchiya, A. and McCabe, C. (2009), ‘Weighting must wait: incorporating equity concerns into cost-effectiveness analysis may take longer than expected’, Pharmacoeconomics, 27(12): 983989.Google Scholar
Weber, R., Ruppik, M., Rickenbach, M., Spoerri, A., Furrer, H., Battegay, M., Cavassini, M., Calmy, A., Bernasconi, E., Schmid, P., Flepp, M., Kowalska, J. and Ledergerber, B. (2013), ‘Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study’, HIV Medicines, 14(4): 195207.Google Scholar
Williams, A. (1997), ‘Intergenerational equity: an exploration of the “fair innings” argument’, Health Economics, 6(2): 117132.Google Scholar
Wilmoth, J. R., Deegan, L. J., Lundstrom, H. and Horiuchi, S. (2000), ‘Increase of maximum life-span in Sweden, 1861-1999’, Science, 289(5488): 23662368.Google Scholar
Zweifel, P., Felder, S. and Meiers, M. (1999), ‘Ageing of population and health care expenditure: a red herring?’, Health Economics, 8(6): 485496.Google Scholar